Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects

Inclusion Criteria: * Male, age 18-55 years, both inclusive, at the time of signing informed consent * Body Mass Index (BMI) 18.5-30 kg/m\^2, both inclusive * Good general health based on assessment of medical history, vital signs, physical examination, ECG (electrocardiogram), and laboratory data at screening, as judged by the investigator Exclusion Criteria: * Known history of thromboembolic event(s) or potential thromboembolic risk as judged by the investigator